Zevra Therapeutics, Inc. ZVRA Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s change in lease liabilities?
- Zevra Therapeutics, Inc. (ZVRA) reported change in lease liabilities of -$123K in Q1 2026.
- How has Zevra Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Zevra Therapeutics, Inc.'s change in lease liabilities increased by 35.3% year-over-year, from -$190K to -$123K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s change in lease liabilities?
- Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s change in lease liabilities has grown at a 27.5% compound annual growth rate (CAGR), from -$326K to -$675K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.